The applicant also asserted that beneficiary access is at risk if CMS payment policies do not reflect the actual cost of providing custom-made, anatomically-designed interbody fusion device technology, like the aprevo Cervical ACDF System, to more Medicare beneficiaries
Obtaining the NEAs Seal of Acceptance requires products to not only exclude certain known irritants and allergens (e.g., formaldehyde, shellac, citrus ingredients, etc.) but also meet specific clinical safety testing requirements.5 This means the product needs to be successfully tested for safety using human subjects
5-Amino-1MQ is not a stimulant it works by inhibiting NNMT to increase NAD+ availability, which supports cellular energy production but does not produce acute alertness or interfere with sleep architecture
Injections bypass this limitation entirely
4 5 In those experiments, L-arginine was a separate experimental substance